Quantitative Structure-Activity Relationship Market

QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Quantitative Structure-Activity Relationship Market contains market size and forecasts of Quantitative Structure-Activity Relationship (QSAR) in Global, including the following market information:
Global Quantitative Structure-Activity Relationship (QSAR) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Quantitative Structure-Activity Relationship (QSAR) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fragment Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Quantitative Structure-Activity Relationship (QSAR) include Protoqsar Sl, Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab and DassaultSystemes. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Quantitative Structure-Activity Relationship (QSAR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Quantitative Structure-Activity Relationship (QSAR) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Quantitative Structure-Activity Relationship (QSAR) Market Segment Percentages, by Type, 2021 (%)
Fragment Based
3D-QSAR
Chemical Descriptor Based
Global Quantitative Structure-Activity Relationship (QSAR) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Quantitative Structure-Activity Relationship (QSAR) Market Segment Percentages, by Application, 2021 (%)
Pharmaceuticals
Cosmetics
Environmental
Food and Beverages
Others
Global Quantitative Structure-Activity Relationship (QSAR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Quantitative Structure-Activity Relationship (QSAR) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Quantitative Structure-Activity Relationship (QSAR) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Quantitative Structure-Activity Relationship (QSAR) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes